Familial Hypercholesterolemia

Main|Search|PHGKB


Last Posted: Dec 09, 2017

---

• Familial Hypercholesterolemia  
  JC Defesche et al, Nat Did Primers, Dec 7, 2017
• PCSK9 Mutations in Familial Hypercholesterolemia: from a Groundbreaking Discovery to Anti-PCSK9 Therapies.  
  El Khoury Petra et al. Current atherosclerosis reports 2017 Oct (12) 49
• Racial, sex disparities persist in familial hypercholesterolemia  
  SM Amrock, Atherosclerosis, Nov 2017
• Reverse cascade screening for familial hypercholesterolemia in high-risk Chinese families.  
  Wu Xue et al. Clinical cardiology 2017 Nov
• A Daughter's Diagnosis, A Mother's Wake-up Call: She knew cholesterol was a family problem, but didn’t take it seriously until it affected her daughter.  
  J Caswell, Heart Insight, Nov 2017
• 2017 FH Global Summit At-a-Glance  
  The FH Foundation, November 2017
• A 3-year study of atorvastatin in children and adolescents with heterozygous familial hypercholesterolemia.  
  Langslet Gisle et al. Journal of clinical lipidology 10(5) 1153-1162.e3
• CaRe high - Cascade screening and registry for high cholesterol in Germany.  
  Schmidt Nina et al. Atherosclerosis. Supplements 2017 Nov 3072-76
• Cascade screening for familial hypercholesterolemia: Practical consequences.  
  Louter Leonora et al. Atherosclerosis. Supplements 2017 Nov 3077-85
• People at risk of familial hypercholesterolaemia should have DNA test, says NICE.  
  et al. BMJ (Clinical research ed.) 2017 Nov 359j5112
• Rapid identification of familial hypercholesterolemia from electronic health records: The SEARCH study.  
  Safarova Maya S et al. Journal of clinical lipidology 10(5) 1230-9
• Health disparities among adult patients with a phenotypic diagnosis of familial hypercholesterolemia in the CASCADE-FH? patient registry.  
  Amrock Stephen M et al. Atherosclerosis 2017 Oct 26719-26
• New Research Identifies Health Disparities Among Adults with Familial Hypercholesterolemia (FH)  
  PR Newswire, Oct 23, 2017
• Is everyone with FH treated equally?  
  S Seim, the FH foundation, October 24, 2017
• Children with hypercholesterolemia of unknown cause: Value of genetic risk scores.  
  Sjouke Barbara et al. Journal of clinical lipidology 10(4) 851-859
• 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia  
  Landmesser U et al, Euro Heart J, October 16, 2017

more